[{"id":"09bf21ce-8df9-42ea-94c7-0c2a334cae0f","acronym":"","url":"https://clinicaltrials.gov/study/NCT02718430","created_at":"2021-01-18T13:17:53.571Z","updated_at":"2024-07-02T16:37:05.907Z","phase":"Phase 1","brief_title":"VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis","source_id_and_acronym":"NCT02718430","lead_sponsor":"Vaximm GmbH","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS mutation","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e VXM01"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 02/01/2016","start_date":" 02/01/2016","primary_txt":" Primary completion: 03/01/2018","primary_completion_date":" 03/01/2018","study_txt":" Completion: 03/01/2018","study_completion_date":" 03/01/2018","last_update_posted":"2018-10-19"}]